Correlation Between Adverum Biotechnologies and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adverum Biotechnologies and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adverum Biotechnologies and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adverum Biotechnologies and Eliem Therapeutics, you can compare the effects of market volatilities on Adverum Biotechnologies and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adverum Biotechnologies with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adverum Biotechnologies and Eliem Therapeutics.
Diversification Opportunities for Adverum Biotechnologies and Eliem Therapeutics
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Adverum and Eliem is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Adverum Biotechnologies and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Adverum Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adverum Biotechnologies are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Adverum Biotechnologies i.e., Adverum Biotechnologies and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Adverum Biotechnologies and Eliem Therapeutics
Given the investment horizon of 90 days Adverum Biotechnologies is expected to generate 0.75 times more return on investment than Eliem Therapeutics. However, Adverum Biotechnologies is 1.33 times less risky than Eliem Therapeutics. It trades about -0.33 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.32 per unit of risk. If you would invest 798.00 in Adverum Biotechnologies on August 26, 2024 and sell it today you would lose (194.00) from holding Adverum Biotechnologies or give up 24.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Adverum Biotechnologies vs. Eliem Therapeutics
Performance |
| Timeline |
| Adverum Biotechnologies |
| Eliem Therapeutics |
Adverum Biotechnologies and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adverum Biotechnologies and Eliem Therapeutics
The main advantage of trading using opposite Adverum Biotechnologies and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adverum Biotechnologies position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Adverum Biotechnologies vs. Eliem Therapeutics | Adverum Biotechnologies vs. HCW Biologics | Adverum Biotechnologies vs. Scpharmaceuticals | Adverum Biotechnologies vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |